Skip to main content

Table 1 Drug-induced neurotoxicity in Parkinson’s disease (PD) (SNC: substantia nigra compacta; MFB: medial forebrain bundle; IC: intracerebral injection; IP: intraperitoneal injection; SC: subcutaneous injection) (Vaccari et al. 2019)

From: A detailed review of pathophysiology, epidemiology, cellular and molecular pathways involved in the development and prognosis of Parkinson's disease with insights into screening models

Sr. no

Neurotoxin

Dose

Animal species

Route of administration

1

6-OHDA

0.032 mg/kg

0.05 mg/kg

0.02–0.16 mg/kg

0.05–0.32 mg/kg

Rat or mice

Rat

Mice

Rat or mice

I.C. into SNC

I.C. into MFB

I.C. into MFB

I.C. into striatum

2

MPTP

33 nmol/24 h

15–20 mg/kg

46 mg/kg

23 mg/kg

Rat

Mice

Mice

Mice

I.C. into SNC/striatum

I.P

I.P. infusion

S.C

3

Paraquat

10 mg/kg

10–15 mg/kg

Mice

Rat or mice

Oral

I.P

4

Rotenone

2–3 mg/kg

5.0 µg

2.75–3.0 mg/kg

50 mg/kg

Rat

Rat

Rat

Mice

S.C. infusion

I.C

I.P

oral